Prostate Cancer - Results from #320

Prostate Cancer and Sleep Disorders: A Systematic Review. April 14, 2022

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC. April 14, 2022

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study. April 13, 2022

Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients. April 13, 2022

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. April 13, 2022

A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer. April 13, 2022

Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer. April 13, 2022

Personalized Medicine in Localized Prostate Cancer: Are We There Yet? April 12, 2022

Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer. April 12, 2022

A Patient-Centered Approach to Research Prioritization in Prostate Cancer. April 12, 2022

Histopathologic and Genetic Features of Mismatch Repair-Deficient High-Grade Prostate Cancer. April 12, 2022

A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate Cancer. April 12, 2022

Prostate cancer polygenic risk score and prediction of lethal prostate cancer. April 12, 2022

Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer. April 12, 2022

New AI Tool for Prostate MRI Analysis to Support PI-RADS Scoring April 11, 2022

Prostate-specific membrane antigen-targeted theranostics: past, present, and future approaches. April 11, 2022

Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized Trial. April 11, 2022

[Multiparametric MRI of the prostate]. April 11, 2022

A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer. April 11, 2022

Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer. April 11, 2022

Page 17 of 1232

email news signup